In Reply to Li Et Al.

Tehran University of Medical Sciences

Science Communicator Platform

Share By

In Reply to Li Et Al. Publisher Pubmed

Darzikolaee NM^{1, 2} ; Bayani R^{2, 3} ; Chavoshi M⁴ ; Kolahdouzan K^{1, 2}

Source: International Journal of Radiation Oncology Biology Physics Published:2023

Abstract

[No abstract available]

Style	Citing Format
MLA	Darzikolaee NM, et al.. "In Reply to Li Et Al.." International Journal of Radiation Oncology Biology Physics, vol. 115, no. 1, 2023, pp. 252-253.
APA	Darzikolaee NM, Bayani R, Chavoshi M, Kolahdouzan K (2023). In Reply to Li Et Al.. International Journal of Radiation Oncology Biology Physics, 115(1), 252-253.
Chicago	Darzikolaee NM, Bayani R, Chavoshi M, Kolahdouzan K. "In Reply to Li Et Al.." International Journal of Radiation Oncology Biology Physics 115, no. 1 (2023): 252-253.
Harvard	Darzikolaee NM et al. (2023) 'In Reply to Li Et Al.', International Journal of Radiation Oncology Biology Physics, 115(1), pp. 252-253.
Vancouver	Darzikolaee NM, Bayani R, Chavoshi M, Kolahdouzan K. In Reply to Li Et Al.. International Journal of Radiation Oncology Biology Physics. 2023;115(1):252-253.
BibTex	@article{ author = {Darzikolaee NM and Bayani R and Chavoshi M and Kolahdouzan K}, title = {In Reply to Li Et Al.}, journal = {International Journal of Radiation Oncology Biology Physics}, volume = {115}, number = {1}, pages = {252-253}, year = {2023} }
RIS	TY - JOUR AU - Darzikolaee NM AU - Bayani R AU - Chavoshi M AU - Kolahdouzan K TI - In Reply to Li Et Al. JO - International Journal of Radiation Oncology Biology Physics VL - 115 IS - 1 SP - 252 EP - 253 PY - 2023 ER -